Rising from the Ashes: OM Investors Stand to Lead Lawsuit
LOS ANGELES, Sept. 11, 2024 — The Schall Law Firm, a national legal eagle in shareholder rights litigation, is blazing a path for investors in a class action lawsuit against Outset Medical, Inc. (OM). This lawsuit brews over violations of the Securities Exchange Act of 1934, putting OM investors in the hot seat.
If you’re an investor who crossed paths with Outset Medical’s securities between August 1, 2022, and August 7, 2024 (the “Class Period”), you best reach out to the firm before October 28, 2024. A loss-suffering shareholder in this scenario? Click here, friend.
There’s a tale of deceit here. Outset Medical hawked its Tablo products as ace for continuous renal replacement therapy, yet the FDA hadn’t okayed them for that job. So, when the market caught wind of Outset’s shenanigans, investor pockets took a hit.
Now, the grapevine carries whispers of legal action and recovery over losses. The Schall Law Firm, renowned for its prowess in securities class actions and shareholder rights, is championing the cause.
Remember, until the class gets its certification, you tread the legal waters solo. Take no action, and you’re a bystander, watching from the wings.
Here’s a tip – keep your ear to the ground for updates, upturns, and treasure hunts. The Outset Medical saga unfolds, and OM investors might steer the ship, guided by The Schall Law Firm.
One thing’s for certain – the legal seas can be stormy, but for OM investors, it’s a chance to navigate the waters of justice and restitution. Dive in and stake your claim, or watch from the shore. The choice is yours.
